Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability-Reference-Cited by-同舟云学术

Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability

Published:2018-08 Issue:2 Volume:150 Page:227-232
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Torres Diogo,Wang Chen^ORCID,Kumar Amanika,Bakkum-Gamez Jamie N.,Weaver Amy L.,McGree Michaela E.,Konecny Gottfried E.,Goode Ellen L.,Cliby William A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference20 articles.

1. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome;Tothill;Clin. Cancer Res.,2008

2. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer;Konecny;J. Natl. Cancer Inst.,2014

3. Pooled clustering of high-grade serous ovarian cancer gene expression leads to novel consensus subtypes associated with survival and surgical outcomes;Wang;Clin. Cancer Res.,2017

4. Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer;Torres;Gynecol. Oncol.,2017

5. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment;Aletti;Gynecol. Oncol.,2011

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer;Biomarker Research;2024-08-12

2. The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers;BMC Cancer;2024-06-07

3. Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer;Journal of Ovarian Research;2024-02-02

4. Prognostic and predictive value of a mRNA signature in high-grade serous ovarian carcinoma with an integrated computation analysis;2023-10-28

5. LncRNA PART1 Regulates Ovarian Carcinoma Development via the miR-150-5p/MYB Axis;Frontiers in Bioscience-Landmark;2023-10-27